Diabetes
Data source : Diabetes Fact sheet N°312– January 2011 – WHO
Diabetes represents an epidemic in most parts of the world with ever more individuals suffering from metabolic syndrome. Obesity and cardiovascular risk factors represent a serious health threat for eventually developing diabetic complications. Pycnogenol® French maritime pine bark extract may assist in alleviating these symptoms in various ways.
In diabetes, the excess amounts of glucose remaining unused in the blood stream may impact the vascular system. Pycnogenol® may help normalize blood sugar levels by slowing the absorption of carbohydrates, which results is a reduced glucose load of the blood stream.
Pycnogenol® significantly delays uptake of complex sugars such as starch. It potently inhibits the digestive enzyme α-glucosidase in the duodenum. Other α-glucosidase inhibitors such as green tea extract, pure catechin and the oral antidiabetic medication acarbose (Precose, Glucobay) are dramatically less potent. Pycnogenol® delays the uptake of glucose from a meal 190 times more potently than prescription medications, preventing the typical high glucose peak in the blood stream after a meal.
More than half the people suffering from diabetes may eventually develop retinopathy, an eye disease caused by capillaries leaking blood into the retina, leading to gradual vision loss.
Five clinical studies with over 1000 patients demonstrated Pycnogenol® strengthens retinal capillaries and preserves eye sight. Recent research on Pycnogenol® and a proprietary bilberry extract shows the ingredient combination normalizes intraocular pressure which significantly reduces the likelihood of developing glaucoma.